Corindus Vascular Robotics (OTC:CVRS) said today that it closed a $15 million private placement round.
The Waltham, Mass.-based medical robotics company said it sold a total of approximately 10.9 million shares of its common stock at a purchase price of approximately $1.38 per share, for aggregate proceeds of approximately $15 million.
Net proceeds from the private placement are expected to be approximately $14.8 million, which the company said it plans to use for general corporate purposes, according to a press release.
Earlier this month, Corindus said that it submitted an application seeking FDA premarket clearance to use its CorPath GRX robotic surgical platform in neurovascular interventions.